STAT3 and Ewing sarcoma: For instance, Thiele et al. have shown the antitumoral activity of the JAK1/2 inhibitor AZD1480 blocking endogenous constitutive and cytokine-induced activation of STAT3 in vitro and suppressing the growth of ES xenografts in vivo [49].